Skip to main content

Table 3 Win ratio analysis comparing pairs of patients on clinically meaningful improvement or decline in the two measures in the order indicated

From: Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease

Measure

Order of comparison of endpoints

FVC % Predicted 6MWT

6MWT FVC % Predicted

Comparison based on the first endpoint in the sequence

  

 Wins

923

786

 Losses

417

330

 Ties

1159

1383

Comparison based on second endpoint in the sequence

  

 Wins

314

391

 Losses

106

253

 Ties

739

739

Totals

  

 Wins

1237

1177

 Losses

523

583

 Ties

739

739

Win ratio (95% CI)

2.37 (1.30, 4.29)

2.02 (1.13, 3.62)

p-value

0.005

0.018

  1. Win ratio is the total wins divided by the total losses
  2. 6MWT six-minute walk test, CI confidence interval, FVC forced vital capacity